Johns Hopkins surgical oncologist Dr. Norman G. Nicolson addresses frequently asked clinical questions about Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Dr. Nicolson discusses patient selection criteria, perioperative considerations, potential risks and benefits, and expected outcomes associated with HIPEC. Gain expert insights into how this procedure integrates into the multidisciplinary management of peritoneal surface malignancies and how it can improve treatment planning for your patients. #hipec #johnshopkins Learn More: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/hipec-surgery-what-you-need-to-know Meet our Expert: https://profiles.hopkinsmedicine.org/provider/norman-greeley-nicolson/2701999 0:16 How has HIPEC evolved since it was first introduced? 1:01 What additional benefits are there for patients since the introduction of HIPEC? 1:25 What types of patients with different GI cancers are eligible for HIPEC? 1:48 What makes Johns Hopkins a unique place to receive HIPEC surgery? 2:26 Where do you see the future of HIPEC going? 2:59 Are there any other patient populations you'd like to evaluate as potential candidates? 3:24 What is the patient evaluation process for HIPEC procedure?